Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Metagenomi Inc (NASDAQ: MGX) was $2.29 for the day, down -0.43% from the previous closing price of $2.3. In other words, the price has decreased by -$0.43 from its previous closing price. On the day, 0.86 million shares were traded. MGX stock price reached its highest trading level at $2.38 during the session, while it also had its lowest trading level at $2.16.
Ratios:
Our analysis of MGX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.36 and its Current Ratio is at 6.36. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on May 07, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
On May 02, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $16 to $6.
On March 05, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $25.Wells Fargo initiated its Overweight rating on March 05, 2024, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 11 ’25 when Noonberg Sarah B. bought 35,832 shares for $1.90 per share.
Sebastian Bernales bought 769,845 shares of MGX for $1,470,404 on Jul 09 ’25. On Jun 06 ’25, another insider, Wein Matthew, who serves as the insider of the company, sold 199 shares for $1.75 each. As a result, the insider received 348 and left with 16,693 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGX now has a Market Capitalization of 85950880 and an Enterprise Value of -76052120. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.55 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at -2.252 whereas that against EBITDA is 0.881.
Stock Price History:
The Beta on a monthly basis for MGX is 0.00, which has changed by 0.05529952 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, MGX has reached a high of $4.92, while it has fallen to a 52-week low of $1.23. The 50-Day Moving Average of the stock is 12.80%, while the 200-Day Moving Average is calculated to be 7.81%.
Shares Statistics:
MGX traded an average of 622.46K shares per day over the past three months and 857440 shares per day over the past ten days. A total of 37.53M shares are outstanding, with a floating share count of 24.06M. Insiders hold about 35.90% of the company’s shares, while institutions hold 19.88% stake in the company. Shares short for MGX as of 1757894400 were 1094418 with a Short Ratio of 1.76, compared to 1755216000 on 1496821. Therefore, it implies a Short% of Shares Outstanding of 1094418 and a Short% of Float of 4.0.
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.44 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$2.18 and -$2.34 for the fiscal current year, implying an average EPS of -$2.27. EPS for the following year is -$1.75, with 3.0 analysts recommending between -$1.2 and -$2.6.
Revenue Estimates
For the next quarter, 5 analysts are estimating revenue of $7.94M. There is a high estimate of $10M for the next quarter, whereas the lowest estimate is $2.5M.
A total of 5 analysts have provided revenue estimates for MGX’s current fiscal year. The highest revenue estimate was $32.64M, while the lowest revenue estimate was $17.6M, resulting in an average revenue estimate of $28.37M. In the same quarter a year ago, actual revenue was $52.3MBased on 5 analysts’ estimates, the company’s revenue will be $28.04M in the next fiscal year. The high estimate is $40M and the low estimate is $10M.
